<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Treatment | smithsonianmag.com</title><link>https://www.smithsonianmag.com/rss/tag/treatment/</link><description>RSS feed for Treatment</description><atom:link href="https://www.smithsonianmag.com/rss/tag/treatment/" rel="self"/><language>en</language><lastBuildDate>Thu, 23 Jul 2026 19:32:27 +0000</lastBuildDate><item><title>Experimental Alzheimer's Drug That Fights a Tough-to-Target Protein Shows Promise at Slowing Cognitive Decline in a Clinical Trial</title><link>https://www.smithsonianmag.com/smart-news/experimental-alzheimers-drug-that-fights-a-tough-to-target-protein-shows-promise-at-slowing-cognitive-decline-in-a-clinical-trial-180989177/</link><description>Recently FDA-approved treatments work to clear clumps of the protein amyloid beta in the brain. A drug that instead goes after tangles of the protein tau can yield similar cognitive outcomes, a new study suggests</description><pubDate>Thu, 23 Jul 2026 19:32:27 +0000</pubDate><guid>https://www.smithsonianmag.com/smart-news/experimental-alzheimers-drug-that-fights-a-tough-to-target-protein-shows-promise-at-slowing-cognitive-decline-in-a-clinical-trial-180989177/</guid><enclosure length="3307502" type="image/png" url="https://th-thumbnailer.cdn-si-edu.com/m7alJHCMgRQ1L4ZK4RmoABr8aeU=/420x240/filters:focal(960x549:961x550)/https://tf-cmsv2-smithsonianmag-media.s3.amazonaws.com/filer_public/c1/a2/c1a2a82f-5e62-4728-a670-4816f111957b/beta-amyloid_plaques_and_tau_in_the_brain_38686503251.png"/></item></channel></rss>